909 chemical innovation drug (class 1 new drugs) registration application acceptance numbers, and 835 approved acceptance numbers (on average, there are 2 acceptance numbers for a variety, which is equivalent to more than 400 new drugs).
There are more and more Parkinson's disease patients around?
Time of Update: 2021-04-18
Professor Liu Yiming said: "In the past, people always thought that trembling of the hands of the elderly was not considered a disease, but in recent years, the number of elderly patients in outpatient clinics has obviously increased.
Drug treatment of early Parkinson's disease, one table summary
Time of Update: 2021-04-18
2. Early PD drug selection, remember two sentences (1) For most patients, the first anti-PD drug is compound levodopa, whether it is late-onset PD or early-onset PD with mental decline.
How much do you know about the treatment of advanced Parkinson's disease?
Time of Update: 2021-04-18
For the treatment of patients with Parkinson's disease in the middle and late stages, it is necessary not only to improve motor symptoms, but also to properly handle some motor complications and non-motor symptoms.
The state takes action! The medical insurance reform that benefits more than 300 million employees will usher in a big move
Time of Update: 2021-04-18
of current employees are still credited to their personal accounts, and all unit payments are credited to the overall fund. This means that the “three-to-seven percent” of the employer's payment part mentioned above will become
The "three brothers" of Parkinson's disease, cancer, and type 2 diabetes are originally in the same line
Time of Update: 2021-04-18
Introduction: Enzymes that play a major role in cancer and type 2 diabetes can also activate the "clear" protein in Parkinson's disease.
How many people have been misunderstood by the 9 major misunderstandings of Parkinson's disease!
Time of Update: 2021-04-18
of Sun Yat-sen University gave us detailed answers. In recent years, people's awareness of the prevention and treatment of Parkinson's disease (PD) has increased compared with the past, but there are still many
R&D intensity of more than 1,200 listed companies: pharmaceutical companies take the top six, but risks also arise!
Time of Update: 2021-04-18
of marketed drugs. It is worth noting that as of the first quarter of this year, Biotech has announced the termination of the development of three new drug projects, including BAT8003 in phase I
Chinese scholars take the lead in cracking the mechanism of plant breeding to help overcome hybridization obstacles
Time of Update: 2021-04-17
/>Chinese scholars take the lead in cracking the mechanism of plant breeding to help overcome hybridization obstacles
Neurology: Interferon signal suppression, will not interfere with Parkinson's disease risk or age of onset
Time of Update: 2021-04-17
preventionIn order to evaluate the effect of long-term tumor necrosis factor (TNF) inhibition on Parkinson's disease (PD) risk and age of onset, they conducted a 2-sample Mendelian randomized study using genome-wide association studies ( GWAS ) summary statistics.
Sci Adv: The "three brothers" of Parkinson's disease, cancer, and type 2 diabetes are originally in the same line
Time of Update: 2021-04-17
called Parkin is eager to protect mitochondria, which are power plants that generate energy for cells. Recently, Salk researchers discovered a direct connection
the exercise performance of elderly patients with mild to moderate Parkinson's disease
Time of Update: 2021-04-16
In summary, the results of the study show that personalized IVGB exercise training can improve the balance and postural stability of elderly people with mild to moderate PD, and prevent falls.
Ann Neurol: Nabirone can effectively and safely treat Parkinson's disease patients with non-motor symptoms
Time of Update: 2021-04-16
A phase II placebo-controlled, double-blind, parallel group, randomized controlled trial investigated Nabilong as a treatment for Parkinson’s disease (PD) non-exercise The effectiveness and safety of symptoms (NMS), research results have been published in Ann Neurol.
Ann Intern Med: Long-term use of fast-acting promethazine does not slow down the clinical progression of early Parkinson's disease
Time of Update: 2021-04-16
and were randomized to receive 5 mg promethazine or placebo twice a day. Lasts for 36 months. The main result was the change in scores in the first to third parts of the Parkinson’s Disease Unified Score Scale (UPDRS
The resignation of the chairman of Weigao shares takes effect two major businesses or splits!
Time of Update: 2021-04-14
|